Anesthesiology and Pain Medicine

Published by: Kowsar

Novel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature Review

Pegah Safaeian 1 , * , Ryan Mattie 2 , Matthew Hahn 3 , Christopher T. Plastaras 3 and Zachary L. McCormick 1 , 4
Authors Information
1 Department of Physical Medicine and Rehabilitation, The Rehabilitation Institute of Chicago, Northwestern Feinberg School of Medicine, Chicago, USA
2 Department of Orthopaedics, Stanford University, Palo Alto, USA
3 Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
4 Department of Anesthesiology, Northwestern Feinberg School of Medicine, Chicago, USA
Article information
  • Anesthesiology and Pain Medicine: April 01, 2016, 6 (2); e33322
  • Published Online: March 1, 2016
  • Article Type: Case Report
  • Received: October 15, 2015
  • Revised: November 30, 2015
  • Accepted: December 20, 2015
  • DOI: 10.5812/aapm.33322

To Cite: Safaeian P, Mattie R, Hahn M, Plastaras C T, McCormick Z L. Novel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature Review, Anesth Pain Med. 2016 ; 6(2):e33322. doi: 10.5812/aapm.33322.

Copyright © 2016, Iranian Society of Regional Anesthesia and Pain Medicine (ISRAPM). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Hansson PT, Attal N, Baron R, Cruccu G. Toward a definition of pharmacoresistant neuropathic pain. Eur J Pain. 2009; 13(5): 439-40[DOI][PubMed]
  • 2. Smith BH, Torrance N. Epidemiology of neuropathic pain and its impact on quality of life. Curr Pain Headache Rep. 2012; 16(3): 191-8[DOI][PubMed]
  • 3. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007; 68(15): 1178-82[DOI][PubMed]
  • 4. Smith BH, Torrance N, Bennett MI, Lee AJ. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain. 2007; 23(2): 143-9[DOI][PubMed]
  • 5. Smith M, Davis MA, Stano M, Whedon JM. Aging baby boomers and the rising cost of chronic back pain: secular trend analysis of longitudinal Medical Expenditures Panel Survey data for years 2000 to 2007. J Manipulative Physiol Ther. 2013; 36(1): 2-11[DOI][PubMed]
  • 6. Ellenberg M. Cervical radiculopathy. Archives of Physical Medicine and Rehabilitation. 1994; 75(3): 342-52[DOI]
  • 7. Malanga GA. The diagnosis and treatment of cervical radiculopathy. Med Sci Sports Exerc. 1997; 29(7 Suppl)-45[PubMed]
  • 8. Frontera WR, Silver JK, Rizzo TD. Essentials of physical medicine and rehabilitation: Musculoskeletal disorders, pain, and rehabilitation. 2008;
  • 9. Luijsterburg PA, Verhagen AP, Ostelo RW, van Os TA, Peul WC, Koes BW. Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review. Eur Spine J. 2007; 16(7): 881-99[DOI][PubMed]
  • 10. Zur E. Topical treatment of neuropathic pain using compounded medications. Clin J Pain. 2014; 30(1): 73-91[DOI][PubMed]
  • 11. Kalso E. The Vicious Circle in chronic pain management: balancing efficacy and adverse effects. Curr Med Res Opin. 2011; 27(10): 2069-71[DOI][PubMed]
  • 12. Galer BS. Topical analgesic medication - the dawn of a new era. Pain. 2009; 147(1-3): 5-6[DOI][PubMed]
  • 13. Boulais N, Misery L. The epidermis: a sensory tissue. Eur J Dermatol. 2008; 18(2): 119-27[DOI][PubMed]
  • 14. Lumpkin EA, Caterina MJ. Mechanisms of sensory transduction in the skin. Nature. 2007; 445(7130): 858-65[DOI][PubMed]
  • 15. Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2011; 4: 11-24[DOI][PubMed]
  • 16. Likar R, Demschar S, Kager I, Neuwersch S, Pipam W, Sittl R. Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster - a case series. Int J Gen Med. 2015; 8: 9-14[DOI][PubMed]
  • 17. Endo Pharmaceuticals. 2013;
  • 18. Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004; 61(6): 914-8[DOI][PubMed]
  • 19. White WT, Patel N, Drass M, Nalamachu S. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003; 4(4): 321-30[PubMed]
  • 20. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003; 106(1-2): 151-8[PubMed]
  • 21. Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002; 18(5): 297-301[PubMed]
  • 22. Devers A, Galer BS. Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain. 2000; 16(3): 205-8[PubMed]
  • 23. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003; 60(11): 1524-34[DOI][PubMed]
  • 24. Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med. 2005; 6(5): 379-84[DOI][PubMed]
  • 25. Fleming JA, O'Connor BD. Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manag. 2009; 14(5): 381-8[PubMed]
  • 26. Lee SS, Sohn YW, Yoo ES, Kim KH. Neurotoxicity and long lasting analgesia induced by capsaicinoids. J Toxicol Sci. 1991; 16 Suppl 1: 3-20[PubMed]
  • 27. Wagner T, Roth-Daniek A, Sell A, England J, Kern KU. Capsaicin 8% patch for peripheral neuropathic pain: review of treatment best practice from 'real-world' clinical experience. Pain Manag. 2012; 2(3): 239-50[DOI][PubMed]
  • 28. Mason L, Moore RA, Edwards JE, McQuay HJ, Derry S, Wiffen PJ. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ. 2004; 328(7446): 995[DOI][PubMed]
  • 29. Watson PNC, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain. 1988; 33(3): 333-40[DOI]
  • 30. Derry S, Sven-Rice A, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013; 2[DOI][PubMed]
  • 31. Mao J, Gold MS, Backonja MM. Combination drug therapy for chronic pain: a call for more clinical studies. J Pain. 2011; 12(2): 157-66[DOI][PubMed]
  • 32. Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain. 2003; 19(5): 323-8[PubMed]
  • 33. McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol. 2000; 49(6): 574-9[PubMed]
  • 34. Visco CJ, Cheng DS, Kennedy DJ. Pharmaceutical therapy for radiculopathy. Phys Med Rehabil Clin N Am. 2011; 22(1): 127-37[DOI][PubMed]
  • 35. Argoff CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013; 88(2): 195-205[DOI][PubMed]
  • 36. Di Rienzo Businco L, Di Rienzo Businco A, D'Emilia M, Lauriello M, Coen Tirelli G. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Acta Otorhinolaryngol Ital. 2004; 24(5): 279-83[PubMed]
  • 37. Nasri-Heir C, Khan J, Heir GM. Topical medications as treatment of neuropathic orofacial pain. Dent Clin North Am. 2013; 57(3): 541-53[DOI][PubMed]
  • 38. Amer MM, Abdelaal Ahmed Mahmoud A, Abdelrahman Mohammed MK, Elsharawy AM, Ahmed DA, Farag EM. Effect of magnesium sulphate on bi-spectral index (BIS) values during general anesthesia in children. BMC Anesthesiol. 2015; 15: 126[DOI][PubMed]
  • 39. Redondo-Castro E, Navarro X. Chronic ibuprofen administration reduces neuropathic pain but does not exert neuroprotection after spinal cord injury in adult rats. Exp Neurol. 2014; 252: 95-103[DOI][PubMed]
  • 40. Cornefjord M, Olmarker K, Otani K, Rydevik B. Nucleus pulposus-induced nerve root injury: effects of diclofenac and ketoprofen. Eur Spine J. 2002; 11(1): 57-61[PubMed]
  • 41. Plaza-Villegas F, Heir G, Markman S, Khan J, Noma N, Benoliel R, et al. Topical pregabalin and diclofenac for the treatment of neuropathic orofacial pain in rats. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114(4): 449-56[DOI][PubMed]
  • 42. Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ Clin Evid. 2014; 1
  • 43. Parmar BS, Shah KH, Gandhi IC. Baclofen in trigeminal neuralgia--a clinical trial. Indian J Dent Res. 1989; 1(4): 109-13[PubMed]
  • 44. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984; 15(3): 240-4[DOI][PubMed]
  • 45. Terrence CF, Fromm GH, Tenicela R. Baclofen as an analgesic in chronic peripheral nerve disease. Eur Neurol. 1985; 24(6): 380-5[PubMed]
  • 46. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain. 1992; 8(4): 338-45[PubMed]
  • 47. Kopsky DJ, Keppel Hesselink JM. Neuropathic pain as a result of acromegaly, treated with topical baclofen cream. J Pain Symptom Manage. 2013; 46(4)-5[DOI][PubMed]
  • 48. Ringel RA, Roy E3. Glossopharyngeal neuralgia: successful treatment with baclofen. Ann Neurol. 1987; 21(5): 514-5[DOI][PubMed]
  • 49. Steardo L, Leo A, Marano E. Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial. Eur Neurol. 1984; 23(1): 51-5[PubMed]
  • 50. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011; 19(6): 833-41[DOI][PubMed]
  • 51. Keppel Hesselink JM, Kopsky DJ, Sajben NL. Vulvodynia and proctodynia treated with topical baclofen 5 % and palmitoylethanolamide. Arch Gynecol Obstet. 2014; 290(2): 389-93[DOI][PubMed]
  • 52. Somberg JC, Molnar J. Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions. Am J Ther. 2015; 22(3): 214-21[DOI][PubMed]
  • 53. Zuniga RE, Schlicht CR, Abram SE. Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology. 2000; 92(3): 876-80[PubMed]
  • 54. Commissiong JW, Karoum F, Reiffenstein RJ, Neff NH. Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effect. Can J Physiol Pharmacol. 1981; 59(1): 37-44[PubMed]
  • 55. Becker DE, Reed KL. Essentials of local anesthetic pharmacology. Anesth Prog. 2006; 53(3): 98-108[DOI][PubMed]
  • 56. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice AS. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014; 4[DOI][PubMed]
  • 57. Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes. 2015; 6(3): 432-44[DOI][PubMed]
  • 58. Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clin Proc. 2015; 90(4): 532-45[DOI][PubMed]
  • 59. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015; 14(2): 162-73[DOI][PubMed]
  • 60. Bryson E, Asbill S, Sweitzer S. Skin permeation and antinociception of topical gabapentin formulations. Int J Pharm Compd. 2014; 18(6): 504-11[PubMed]
  • 61. Hiom S, Patel GK, Newcombe RG, Khot S, Martin C. Severe postherpetic neuralgia and other neuropathic pain syndromes alleviated by topical gabapentin. Br J Dermatol. 2015; 173(1): 300-2[DOI][PubMed]
  • 62. Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008; 112(3): 579-85[DOI][PubMed]
  • 63. Yildirim K, Deniz O, Gureser G, Karatay S, Ugur M, Erdal A, et al. Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. J Back Musculoskelet Rehabil. 2009; 22(1): 17-20[DOI][PubMed]
  • 64. Kasimcan O, Kaptan H. Efficacy of gabapentin for radiculopathy caused by lumbar spinal stenosis and lumbar disk hernia. Neurol Med Chir (Tokyo). 2010; 50(12): 1070-3[PubMed]
  • 65. Cohen SP, Hanling S, Bicket MC, White RL, Veizi E, Kurihara C, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. BMJ. 2015; 350[DOI][PubMed]
  • 66. Ward A, Clissold SP. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987; 34(1): 50-97[PubMed]
  • 67. Genevay S, Finckh A, Payer M, Mezin F, Tessitore E, Gabay C, et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine (Phila Pa 1976). 2008; 33(19): 2041-6[DOI][PubMed]
  • 68. Georges C, Lefaix JL, Delanian S. Case report: resolution of symptomatic epidural fibrosis following treatment with combined pentoxifylline-tocopherol. Br J Radiol. 2004; 77(922): 885-7[DOI][PubMed]
  • 69. Delanian S, Lefaix JL, Maisonobe T, Salachas F, Pradat PF. Significant clinical improvement in radiation-induced lumbosacral polyradiculopathy by a treatment combining pentoxifylline, tocopherol, and clodronate (Pentoclo). J Neurol Sci. 2008; 275(1-2): 164-6[DOI][PubMed]
  • 70. Giraudeau B, Rozenberg S, Valat JP. Assessment of the clinically relevant change in pain for patients with sciatica. Ann Rheum Dis. 2004; 63(9): 1180-1[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments